Livzon Pharmaceutical Group Inc.
000513
주식 순위
#4689
Livzon Pharmaceutical Group Inc., headquartered in Zhuhai, China, and... Livzon Pharmaceutical Group Inc., headquartered in Zhuhai, China, and established in 1985, is a biopharmaceutical enterprise operating across the entire spectrum of pharmaceutical activities, from research and development to manufacturing and commercialization. The company's operations encompass a diverse range of finished drug products, active pharmaceutical ingredients (APIs), and chemical intermediates, primarily serving the Chinese market while also engaging in international exports. Its pharmaceutical portfolio includes treatments such as Ilaprazole enteric coated tablets for duodenal ulcers and reflux esophagitis, Laprazole sodium injection for managing peptic ulcer bleeding, Leuprorelin Acetate Microspheres for injection, and Urofollitropin injection for anovulation and fertility support. Livzon also produces Perospirone Hydrochloride for schizophrenia, Anti-viral Granules targeting upper respiratory tract infections and influenza, and Shenqi Fuzheng Injection, which addresses general weakness, fatigue, spontaneous sweating, and vertigo, and provides supportive care for lung and stomach cancer patients. Beyond therapeutic drugs, Livzon Pharmaceutical Group develops and distributes a variety of diagnostic reagents. These include kits for detecting IgM/IgG antibodies to coronavirus, nucleic acid tests for human immunodeficiency virus type 1, antinuclear antibody test kits, interferon-gamma release assay kits, and rapid tests for mycoplasma pneumoniae IgM antibodies. The company's extensive offerings further extend to biochemical drugs, microbiological preparations, biologics, traditional Chinese medicine formulations, pharmaceutical raw materials, and antibiotics.
주가
$3.90
시가총액
$3.17B
변동 (1일)
-3.49%
변동 (1년)
-25.88%
국가
CN
거래 Livzon Pharmaceutical Group Inc. (000513)
카테고리
Healthcare
Livzon Pharmaceutical Group Inc. (000513)의 EPS
June 2026 기준 EPS TTM: $0.28
Livzon Pharmaceutical Group Inc.의 최신 재무 보고서와 주가에 따르면, 현재 EPS (TTM)는 $0.28입니다. 2024년 말에는 회사의 EPS가 $0.31였으며, 이는 2023년의 EPS $0.30와 증가입니다.
Livzon Pharmaceutical Group Inc.의 EPS 기록 (2001 ~ 2026)
매년 말의 EPS
| 연도 | EPS | 변화 |
|---|---|---|
| 2026 (TTM) | $0.28 | -11.56% |
| 2025 | $0.32 | 5.73% |
| 2024 | $0.31 | 3.44% |
| 2023 | $0.30 | 0.34% |
| 2022 | $0.30 | -1.07% |
| 2021 | $0.30 | 6.71% |
| 2020 | $0.28 | 40.33% |
| 2019 | $0.20 | 18.39% |
| 2018 | $0.17 | -77.05% |
| 2017 | $0.73 | 466.90% |
| 2016 | $0.13 | 13.68% |
| 2015 | $0.11 | 15.74% |
| 2014 | $0.10 | 3.03% |
| 2013 | $0.10 | 14.63% |
| 2012 | $0.08 | 22.29% |
| 2011 | $0.07 | -10.03% |
| 2010 | $0.08 | -7.56% |
| 2009 | $0.08 | 842.53% |
| 2008 | $0.01 | -89.04% |
| 2007 | $0.08 | 195.17% |
| 2006 | $0.03 | 80.54% |
| 2005 | $0.01 | -11.83% |
| 2004 | $0.02 | 7.64% |
| 2003 | $0.02 | 45.37% |
| 2002 | $0.01 | 27.06% |
| 2001 | $0.01 | 0.00% |
유사 기업 또는 경쟁사의 EPS
| 회사 | EPS | EPS 차이 | 국가 |
|---|---|---|---|
| $6.55 | 2,213.50% |
DE
|
|
| $6.12 | 2,062.69% |
DE
|
|
| $0.72 | 155.51% |
JP
|
|
| $3.66 | 1,193.29% |
CH
|
|
| $0.53 | 88.59% |
IN
|
